Hester Biosciences Limited (NSE:HESTERBIO)
India
· Delayed Price · Currency is INR 1,762.80
+2.80 (0.16%)
May 22, 2025, 3:29 PM IST
Hester Biosciences Revenue
In the fiscal year ending March 31, 2025, Hester Biosciences had annual revenue of 3.15B INR with 1.23% growth. Hester Biosciences had revenue of 749.75M in the quarter ending March 31, 2025, a decrease of -5.58%.
Revenue
3.15B
Revenue Growth
+1.23%
P/S Ratio
4.77
Revenue / Employee
4.91M
Employees
642
Market Cap
15.04B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 3.15B | 38.32M | 1.23% |
| Mar 31, 2024 | 3.11B | 329.89M | 11.86% |
| Mar 31, 2023 | 2.78B | 315.58M | 12.79% |
| Mar 31, 2022 | 2.47B | 289.51M | 13.30% |
| Mar 31, 2021 | 2.18B | 299.33M | 15.94% |
| Mar 31, 2020 | Pro | Pro | Pro |
| Mar 31, 2019 | Pro | Pro | Pro |
| Mar 31, 2018 | Pro | Pro | Pro |
| Mar 31, 2017 | Pro | Pro | Pro |
| Mar 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sun Pharmaceutical Industries | 516.03B |
| Divi's Laboratories | 90.78B |
| Cipla | 271.45B |
| Mankind Pharma | 127.44B |
| Apollo Hospitals Enterprise | 211.46B |
| Zydus Lifesciences | 232.42B |
| Aurobindo Pharma | 309.22B |
| Alkem Laboratories | 127.57B |
Hester Biosciences News
- 3 months ago - India's Animal Healthcare Industry on a High-Growth Trajectory, Projected to Reach USD 2.0 Billion by 2034| Exclusive Report by Transparency Market Research Inc. - Benzinga